Journals / Turkish Journal of Hematology / 2001 / Cilt: 18 - Sayı: 3

A case with micromegakaryocytes

Pages
203–206
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Micromegakaryocytes must always be treated with suspicion, as they may provide an important clue for dyshematopoesis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A boy with no previous history of bleeding presented with ecchymoses and splenomegaly.
📊
Key Findings & Data:He was followed up for thrombocytopenia and micromegakaryocytes for 20 months till clinically malignancy was diagnosed.
💡
Conclusion & Impact:Micromegakaryocytes must always be treated with suspicion, as they may provide an important clue for dyshematopoesis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lösemi · Megakaryositler · Kemik iliği

Özet

A boy with no previous history of bleeding presented with ecchymoses and splenomegaly. He was followed up for thrombocytopenia and micromegakaryocytes for 20 months till clinically malignancy was diagnosed. Micromegakaryocytes must always be treated with suspicion, as they may provide an important clue for dyshematopoesis.

🔖

Cite This Article

CELKAN, T., APAK, H., ÖZKAN, A., AKI, H., TAŞYÜREKLİ, M., YÜKSEL, L., YILDIZ, İ. (2001). A case with micromegakaryocytes. Turkish Journal of Hematology, Cilt: 18 - Sayı: 3, 203–206. https://ajindex.com/articles/412980

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Smith OW. Inherited and congenital thrombocytopenia. In: Lilleyman J, Hann I, Blanchette V (eds). Pediatric Hematology. Second Edition, Churchill Livingstone Company, and London 1999:419-37
  2. Zucker-Franklin D. Megakaryocyte morphology and function. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology. 4th edition, McGraw- Hill Book Company USA 1990;1161-72
  3. Levine RF, Hazzard KC, Lamberg JD. The significance of megakaryocyte size. Blood 1982;60: 1122-31
  4. Levine RF. Isolation and characterization of normal human megakaryocytes. Br J Haematol 1980;45: 487-97
  5. Koeffler HP. Myelodysplastic Syndromes. Sem Hematol 1996;33:87-94
  6. Thiele J, Quitmann H, Wagner S, Fischer R. Dysmegakaryopoiesis in MDS: An immunomorphometric study of bone marrow trephine biopsy specimens. J Clin Pathol 1991;44:300-5
  7. Wiesneth M, Pflieger H, Kubanek B, Heimpel H. Micromegakaryocytes in human bone marrow. Acta Haematol 1980;64:65-71
  8. Ohshima K, Kikuchi M, Takeshida M. A megakaryocyte analysis of the bone marrow in-patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. J Pathol 1995;177:181-9
  9. Wong KF, Chan JK. Are “dysplastic” and hypogranular megakaryocytes specific markers for myelodysplastic syndrome? Br J Haematol 1991;77: 509-14
  10. Olson TA, Levine RF, Kelleher J. Familial Thrombocytopenia with Micromegakaryocytes. Am J Pediatr Hematol Oncol 1992;14:248-54.